Company/Division name | On Demand Pharmaceuticals |
Type of work | Manufacturing |
Reshoring category: | Reshoring |
Total number of jobs (added or to be added): | 75 |
Year reshoring announced: | 2021 |
Year reshoring implemented or to be implemented: | 2021 |
Domestically, the work will be done: | In-house |
City reshored to: | Rockville |
State(s) reshored to: | MD |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | Pharmacy on Demand (PoD) technology |
What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |
What domestic positive factors made reshoring more attractive? | Customization/Flexibility, Government Incentives, covid-19 |
Government Incentive dollar amount: | $20 million contract |